Working… Menu

A Study to Assess the Safety and Pharmacokinetics of HBI-002, an Oral Carbon Monoxide Therapeutic, in Healthy Volunteers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03926819
Recruitment Status : Not yet recruiting
First Posted : April 25, 2019
Last Update Posted : February 12, 2021
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by (Responsible Party):
Hillhurst Biopharmaceuticals, Inc.

No Study Results Posted on for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : September 2021
Estimated Study Completion Date : October 2021